Press Centre
Press Releases
Annual General Meeting 2009
Phynova Group plc
("Phynova")
Annual General Meeting 2009
Phynova Group plc (AIM: PYN, OTCQX: PHNVY), the developer of prescription pharmaceuticals derived from plants used in Chinese medicines, held its Annual General Meeting at Phynova´s offices in Long Hanborough today. All resolutions put to the shareholders, as set out in the notice of annual general meeting dated 20 February 2009, were passed by the necessary majorities.
- Ends -
For further information, please contact:
Phynova Group PLC
+44 (0) 1993 880700
John Pool (Executive Chairman)
Tony Mills (CEO Phynova Limited)
Robert Miller (CEO Phynova China Limited)
Nominated Adviser:
John East & Partners Limited
+44 (0) 20 7618 2200
Simon Clements
Broker:
Evolution Securities China Limited
+44 (0) 20 7071 4389
Barry Saint
Media enquiries:
Capital MS&L
+44 (0) 20 7307 5330
Mary Clark/Anna Mitchell
Notes to Editors:
About Phynova
Phynova is a UK company developing new prescription pharmaceuticals derived from plants used in Chinese medicines. The Company is focused on viral and bacterial diseases, metabolic diseases and cancer. Phynova´s lead product for hepatitis C has now completed a Phase I/II trial in the US. Two further products, for fatty liver disease and post-operative ileus, are targeted for entry to the clinic and there are a further four products in preclinical development.
For further information please visit www.phynova.com.
19/03/2009
<< Back | See all current Press releses